About Us

About Us

History

2021
12
Permission for Manufacturing Advanced Biological Products
09
Strategic investment(20 million USD)
06

Completion of GMP facility

Series B financing(48 million USD)

05
MOU with Ewha University Medical Center
01

MOU with International Vaccine Institute(IVI)

MOU with Severance hospital

MOU with GI-BIOME

2020
12
Awardee of ‘Cytiva Korea CEO award’ at the 2020 Bio Challenge
10
Success in Scale-up to 50L of T.O.P. NK
07
Research Collaboration with Miltenyi Biotec Inc.
06
Series A financing(26 million USD)
04
Nano NK research on the cover of Advanced Material Journal (IF=30.85)
2019
07
Non-exclusive agreement of GI-101
05
Registration of our affiliate R&D center
02
Accreditation as a bio-venture
01
In-licensing of Nano NK cell
2018
10

In-licensing for Drone Treg cell

Foundation of GI-Cell